Agios Pharmaceuticals CEO Jacqualyn Fouse's 2020 pay falls 54% to $7.6M
Agios Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 8, 2021
Agios Pharmaceuticals reported fiscal year 2020 executive compensation information on April 8, 2021.
In 2020, five executives at Agios Pharmaceuticals received on average a compensation package of $3.5M, a 37% decrease compared to previous year.
Average pay of disclosed executives at Agios Pharmaceuticals
Jacqualyn A. Fouse, Chief Executive Officer, received $7.6M in total, which decreased by 54% compared to 2019. 60% of Fouse's compensation, or $4.6M, was in option awards. Fouse also received $510K in non-equity incentive plan, $747K in salary, $1.8M in stock awards, as well as $11K in other compensation.
For fiscal year 2020, the median employee pay was $253,211 at Agios Pharmaceuticals. Therefore, the ratio of Jacqualyn A. Fouse's pay to the median employee pay was 30 to one.
Bruce Car, Chief Scientific Officer, received a compensation package of $3.2M. 46% of the compensation package, or $1.5M, was in option awards.
Christopher Bowden, Chief Medical Officer, earned $2.9M in 2020, a 10% decrease compared to previous year.
Andrew Hirsch, Chief Financial Officer, received $2.9M in 2020, which decreases by 32% compared to 2019.
Jonathan Biller, Chief Financial Officer, earned $769K in 2020, a 76% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 8, 2021.